Steroid Treatment Linked To Better EEG And Thinking

What was studied

This study looked at children with developmental and/or epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS), a rare paediatric epileptic encephalopathy in which epileptiform discharges become markedly activated during non-REM sleep and can be linked with seizures and neurocognitive regression.

The researchers followed 29 children from two tertiary centers in India for 2 years. All children received a structured course of intravenous methylprednisolone, a steroid, once a month for 3 days over 6 months, while their anti-seizure medicines were kept stable. The team used serial overnight EEGs and neuropsychological testing to track seizures, sleep-related EEG changes, and cognitive skills over time.

What they found

During and after pulse IVMP treatment, seizure frequency and the amount of abnormal spike-wave activity on EEG both decreased significantly, and these changes were sustained through 24 months. Some EEG improvement occurred early, while the spike dipole stability quotient (SQ), described in the study as a qualitative marker of cortical source coherence, increased more gradually and improved significantly only after 12 months.

Children with idiopathic D/EE-SWAS showed more durable electroclinical improvement. Children with symptomatic D/EE-SWAS showed initial improvement, with partial relapse by 2 years. On cognitive testing, the group overall showed significant improvement in attention and verbal learning, while broader domain-specific cognitive improvement was reported mainly in the idiopathic group. The study also found that higher SWI and lower SQ at 6 months were associated with higher seizure frequency at 24 months.

Limits of the evidence

This was a prospective cohort study, not a randomized trial, so it cannot show from this design alone that the steroid treatment caused the improvements. There was no comparison group receiving a different treatment or no steroid treatment.

The study was small, with 29 children from two centers in India, so the results may not apply to all children with D/EE-SWAS. The abstract does not report detailed information about side effects, dropouts, or baseline differences between groups, which limits how fully the treatment can be judged. The abstract also gives only limited detail about the neuropsychology results in each subgroup.

For families and caregivers

This study suggests that a structured pulse steroid treatment plan was associated with fewer seizures and improved EEG findings in children with D/EE-SWAS over follow-up, and that attention and verbal learning improved overall. It also suggests that the cause of the condition may matter: children with idiopathic disease appeared to have more durable long-term improvement than those with symptomatic disease.

For families, one possible takeaway is that EEG changes early in treatment may help doctors estimate longer-term seizure control, but the evidence is still limited. The study supports pulse steroid treatment as one possible approach, but it does not show that this approach works for every child or that it is better than other treatments.

What to watch next

Larger comparative studies could help clarify how pulse steroids perform against other treatments and could report side effects and long-term cognitive outcomes in more detail.

Terms in this summary

D/EE-SWAS

A rare childhood epileptic encephalopathy in which epileptiform activity becomes markedly activated during sleep and can affect development and cognition.

EEG

A test that records the brain's electrical activity using sensors placed on the scalp.

Spike-wave index (SWI)

A measure of how much of sleep is filled with abnormal spike-wave activity on EEG.

Intravenous methylprednisolone (IVMP)

A steroid medicine given through a vein.

Idiopathic

A condition with no clear cause identified.

Symptomatic

A condition linked to an underlying known cause or brain problem.

Neuropsychological testing

Tests that measure skills such as attention, memory, executive function, visuospatial abilities, and adaptive functioning.

Biomarker

A measurable sign that may help predict how a disease will behave or respond to treatment.